Leadership & Pay ·
On August 12, 2026, Omeros Corporation's Board of Directors increased its size to nine members and appointed Joseph…
OMEROmeros Corp
On August 12, 2026, Omeros Corporation's Board of Directors increased its size to nine members and appointed Joseph Schocken as a director, effective immediately. Mr. Schocken will serve until the 2027 annual meeting and was also appointed to the Audit Committee. He is the founder of Tranceka Capital LLC and former CEO of Broadmark Realty Capital, Inc. As part of his appointment, he received a stock option for 30,000 shares under the company's non-employee director compensation policy. Omeros Corporation operates in the biopharmaceutical industry, focusing on the development of therapies for inflammatory diseases.